HHV-6 Reactivation and Associated Sequelae after Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 11, 2012, Pages 1700-1708

  Zerr, Danielle M ^a,c   Boeckh, Michael ^b,d   Delaney, Colleen ^a,d   Martin, Paul J ^b,d   Xie, Hu ^d   Adler, Amanda L ^c   Huang, Meei Li ^d   Corey, Lawrence ^d   Leisenring, Wendy M ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Acute graft versus host disease; Cytomegalovirus; Hematopoietic cell transplantation; Human herpesvirus 6; Mortality

Indexed keywords

VIRUS DNA;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; COMORBIDITY; CYTOMEGALOVIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN HERPESVIRUS 6; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; NONHUMAN; OUTCOME ASSESSMENT; RISK FACTOR; VIRUS DETECTION; VIRUS REACTIVATION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHILD; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ROSEOLOVIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; VIRUS ACTIVATION;

EID: 84867541229     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.05.012     Document Type: Article

References (36)

1. Okuno T., Takahashi K., Balachandra K., et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989, 27:651-653.
2. Hentrich M., Oruzio D., Jäger G., et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005, 128:66-72.
3. Imbert-Marcille B.M., Tang X.W., Lepelletier D., et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 2000, 31:881-886.
4. Zerr D.M., Corey L., Kim H.W., Huang M.L., Nguy L., Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40:932-940.
5. Tormo N., Solano C., de la Cámara R., et al. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2010, 16:653-661.
6. de Pagter P.J., Schuurman R., Visscher H., et al. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol Blood Marrow Transplant 2008, 14:831-839.
7. Wang L.R., Dong L.J., Zhang M.J., Lu D.P. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 42:673-677.
8. Zerr D.M., Fann J.R., Breiger D., et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 2011, 117:5243-5249.
9. Clark D.A., Nacheva E.P., Leong H.N., et al. Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis 2006, 193:912-916.
10. Boeckh M., Bowden R.A., Gooley T., Myerson D., Corey L. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood 1999, 93:1781-1782.
11. Boeckh M., Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009, 113:5711-5719.
12. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001, 344:175-181.
13. Sorror M.L., Giralt S., Sandmaier B.M., et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 2007, 110:4606-4613.
14. Leisenring W.M., Martin P.J., Petersdorf E.W., et al. An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood 2006, 108:749-755.
15. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
16. Zerr D.M., Gupta D., Huang M.L., Carter R., Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:309-317.
17. Appleton A.L., Sviland L., Peiris J.S., et al. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. Bone Marrow Transplant 1995, 16:777-782.
18. MacMillan M.L., Weisdorf D.J., Brunstein C.G., et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009, 113:2410-2415.
19. Yoshikawa T., Ihira M., Ohashi M., et al. Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001, 28:77-81.
20. Yoshikawa T., Asano Y., Ihira M., et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002, 185:847-853.
21. Volin L., Lautenschlager I., Juvonen E., Nihtinen A., Anttila V.J., Ruutu T. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 2004, 126:690-696.
22. Wang L.R., Dong L.J., Zhang M.J., Lu D.P. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006, 12:1031-1037.
23. Zerr D.M., Meier A.S., Selke S.S., et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005, 352:768-776.
24. Mayne M., Cheadle C., Soldan S.S., et al. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J Virol 2001, 75:11641-11650.
25. Ogata M., Satou T., Kawano R., et al. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2010, 45:129-136.
26. Fujita A., Ihira M., Suzuki R., et al. Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients. J Infect 2008, 57:241-248.
27. Ju X.P., Xu B., Xiao Z.P., et al. Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 2005, 35:1179-1186.
28. Mohty M., Blaise D., Faucher C., et al. Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation. Blood 2005, 106:4407-4411.
29. Shaiegan M., Iravani M., Babaee G.R., Ghavamzadeh A. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients. Transpl Immunol 2006, 15:223-227.
30. Fujii N., Hiraki A., Aoe K., et al. Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array. Int J Mol Med 2006, 17:881-885.
31. Smith A., Santoro F., Di Lullo G., Dagna L., Verani A., Lusso P. Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003, 102:2877-2884.
32. Smith A.P., Paolucci C., Di Lullo G., Burastero S.E., Santoro F., Lusso P. Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J Virol 2005, 79:2807-2813.
33. Lusso P. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J Clin Virol 2006, 37(suppl 1):S4-10.
34. Humar A., Malkan G., Moussa G., Greig P., Levy G., Mazzulli T. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 2000, 181:1450-1453.
35. Humar A., Kumar D., Caliendo A.M., et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 2002, 73:599-604.
36. Wang F.Z., Larsson K., Linde A., Ljungman P. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2002, 30:521-526.